BioRestorative Therapies Appoints ProActive Capital Group as Capital Markets & Digital Media Advisor Initiates New Capital Markets and Digital Media Program
JUPITER, Fla., April 23, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTXD), a life sciences company focused on stem cell based cellular therapies for various personal medical applications, today announced the appointment of ProActive Capital Group as its new Capital Markets Advisory and Digital Media Strategies firm.
"We are very pleased to have retained the services of ProActive Capital Group," stated Mark Weinreb, President and CEO of BRT. "They are an extremely focused firm, their reputation in the industry is top-notch and we are excited to embark on an effective capital markets and digital media program. With upcoming key milestones quickly approaching, we felt that now was the opportune time to embark on a significant new program so that we can achieve a fair valuation that clearly reflects the intrinsic value of our scientific initiatives."
"We are pleased to have been selected by BRT, a leading company in the next generation of stem cell therapies," stated Jeff Ramson, Founder and CEO of ProActive Capital Group. "We look forward to implementing a quality capital markets and digital media strategies program to increase BRT's awareness among the investment community. We strongly believe that the company has significant growth prospects as it executes its growth strategy."
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. ("BRT"), http://www.biorestorative.com, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, and allowing patients to undergo minimally invasive cellular-based treatments. BRT is developing the following scientific initiatives: Our brtxDISC™ Program (Disc Implanted Stem Cells) offers a non-surgical treatment for bulging and herniated discs and addresses the gap between non-invasive and invasive back procedures. Our ThermoStem® Program focuses on treatments, using brown fat stem cells, for metabolic disorders (diabetes, heart disease, etc.) and obesity primarily focusing on potentially preventing the onset of Type 2 Diabetes. Initial research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels in the body. Our brtx-C Cosmetic Program is based on its development of an extract that, when applied to human skin cells, causes a significant increase in the production of collagen and fibronectin, which are proteins that are essential to combating the aging of skin. The Company also offers plant stem cell-based facial creams and products under the Stem Pearls® brand at www.stempearls.com.
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
SOURCE BioRestorative Therapies, Inc.